Recipharm invests $750k in new GMP suite

By Melissa Fassbender contact

- Last updated on GMT

The suite during an MDI manufacturing process. (Image: Recipharm)
The suite during an MDI manufacturing process. (Image: Recipharm)

Related tags: Research triangle park

Recipharm has opened a new GMP suite for clinical trial material manufacture at its North Carolina-based facility in Research Triangle Park.

The new suite enables the contract development and manufacturing organization (CDMO) to provide complete early development services at the Research Triangle Park location. These services include process development and scale-up, CTM manufacturing and packaging, product release and stability programs.

Ann Flodin, VP and General Manager at Recipharm Laboratories, explained the facility supports the manufacture of different non-sterile dosage forms, such as metered dose inhalers, semi-solids, and dry powder capsules.  

With this location being Recipharm’s center of excellence for orally inhaled and nasal drug products, and with an experienced research team in place, this is a natural development for the company, extending the capabilities of Recipharm group​,” Flodin told Outsourcing-Pharma.com.

The GMP suite is ISO 8 certified, features a walk-in downflow booth, and has the capacity to produce metered dose inhalers in up to 25L batches and offers semi-solid production capabilities up to 20L.

We see the inhalation and semi-solid industries growing, and needing additional clinical trial manufacturing support," ​Flodin added.

"Also, the location is central in Research Triangle Park which is a rapidly growing science and technology cluster, with easy access for visitors through the nearby RDU airport​.”

Related news

Show more

Related products

show more

Eastern & Western Manufacturing Solutions

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 07-Dec-2021 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

Flexibility and capability in pre-filled syringes

Flexibility and capability in pre-filled syringes

Curia | 15-Nov-2021 | Technical / White Paper

Pre-filled syringes have risen in popularity in recent years but the pandemic’s impact on drug development, manufacturing and patient care has created...

Related suppliers

Follow us

Products

View more

Webinars